CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using the patient's own T-cells to target tumors.

Researchers have developed a magnetic nanomaterial that can kill bone cancer cells and support bone regeneration at the same ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

A recent study published in the medical journal Gut has revealed a novel cancer-promoting mechanism of Streptococcus ...

Clinical study from Baylor College of Medicine demonstrates a favorable safety profile and up to 84.6% disease control rate in patients with ...

PKM2 acts like a switch for cellular energy, directly determining whether cancer cells can rapidly generate energy and biosynthetic precursors to support their continued growth. Using a driving ...

Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by ...

A new study has found that high uptake of school-based immunisation against human papillomavirus (HPV) could also offer ...